Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recross Study

NCT02234804 is registered in ClinicalTrials.gov with Aarhus University Hospital Skejby as lead sponsor.

NCT NCT02234804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02234804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recross Study
Lead sponsor
Aarhus University Hospital Skejby
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2013
Completion date
February 28, 2017
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary disease